With his selection as the new Editor-in-Chief of Transplantation Journals (starting January 1, 2025), Stefan Tullius has decided to step down as TTS Vice President. Consequently, we will be holding a by-election for the position of TTS Vice President for a period of two years. To be eligible to run, applicants must have served on the council for a complete term. Our staff will send an email notification to all members who are eligible to run for the position. If you are unsure of your eligibility, please email membership@tts.org.
Just Released - Transplantation Journal - June Issue
The June issue of Transplantation Directjam-packed with articles on a wide-variety of topics affecting different transplanted organs including kidney, liver, heart, pancreas, intestine, multi-organ, VCA, and others. Just to name a few themes, infectious disease topics are covered related to CMV, EBV, HIV, hepatitis E and cryptococcus, as well as COVID vaccination. There are overviews on the urobiome, left ventricular hypertrophy in kidney transplantation and the use of cytopheric devices for pre-transplant bridging. Machine perfusion studies are represented, and also various studies on surgical aspects of transplantation related to intestinal/multi-organ surgeries, new techniques in HCC liver transplant recipients, and an assessment of surgical complications after kidney transplantation. Organ donation topics include articles on organ underutilization, live donor mental health, variations in DCD liver transplant protocols in the U.S., improved treatments of uDCD kidneys for transplantation, and organ access for small recipients. This is just a sampling of topics to highlight, so please visit our open-access Transplantation Direct website for full details of these and other articles of interest.
New for TTS 2024! Guest Speakers to kick off the abstract sessions!
This year, we are bringing a fresh and dynamic start to our sessions by featuring esteemed experts who will ignite the discussion with their insightful perspectives and cutting-edge research. These speakers are leaders in their fields and are sure to inspire and energize our attendees, setting the perfect tone for a day of engaging and thought-provoking presentations.
Don’t miss this unique opportunity to gain valuable insights from the best in the industry. Join us as we elevate our abstract sessions to new heights!
Session: Tackling global ethical issues in transplantation
What next for transplant ethics in the era of xenotransplantation? - Dominique Martin, Australia
Session: Predictive model in transplantation Predicting kidney allograft rejection using blood biomarkers: a prospective multicenter unselected cohort study (EU-TRAIN) - Valentin Goutaudier, France
Session: Cutting-edge of VCA transplantation
The world’s first combined face and whole-eye transplant: Technical aspects, surgical underpinnings, and 1-year outcomes - Bruce Gelb, United States
Session: Kidney Transplant - Donor and Recipient Issues The US model of continuous distribution of donated organs: Better or worse - Matthew Cooper, United States
We are proud to announce that the TTS 2024 Congress has been recognized as compliant by the Conference Vetting System (CVS) and e4ethics. This recognition underscores our commitment to transparency and ethical standards in medical education.
Our two headquarter hotels have sold out; however, we have negotiated a lower rate for the Hilton Istanbul Bosphorus, which has been added as a new headquarter hotel. We have a range of hotels to select from, but they are filling up quickly. Book today!
Notifications for the TTS Scientific Congress Awards were emailed out, check you inbox for your notification! If you have any questions please email program@tts2024.org.
TTS @ATC2024 - Philadelphia, USA - June 1-5, 2024
Pictured from left to right: Jennifer Groverman (Manager, DICG & Projects) Marcelle McPhaden (TTS Executive Director) and Marcelo Cantarovich (TTS Immediate Past President)
It was great to interact with current and future TTS members, take in a few sessions on big ideas in transplant, conduct meetings with other societies and related organizations and to engage with corporate partners at ATC 2024.
With abstract acceptances released the same week there was much excitement about TTS 2024 in Istanbul Sept 22-25, 2024, and also WTC 2025 August 2-6, 2025 in San Francisco.
If we missed you, or you have any questions or input, please reach to us at info@tts.org.
CAST 2023 - Hong Kong Recordings
As part of our collaboration with the Asian Society of Transplantation (AST), our members have access to the recordings from the CAST 2023 Congress. We would like to thank Maggie Ma (AST President), the CAST speakers, and all the CAST committee members who worked tirelessly to realize this successful congress. We look forward to ongoing and long-standing friendship.
5th Summit on Stem Cell Derived Islets - Call for Abstracts
On behalf of the International Pancreas and Islet Transplant Association (IPITA), the Harvard Stem Cell Institute (HSCI) and Juvenile Diabetes Research Foundation (JDRF), we are pleased to announce the 5th Summit on Stem Cell Derived Islets to be held at the Joseph B. Martin Conference Center in Boston, MA, USA from October 28-29, 2024. Visit www.stemcellislet.ipita.org for complete Summit details and to register today!
Gas6/AXL Alleviates Hepatic Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the PI3K/AKT Pathway
Hepatic ischemia/reperfusion (I/R) injury is a major cause of complications in clinical liver surgery. AXL receptor tyrosine kinase (AXL) is a member of the TAM receptor tyrosine kinase family (TYRO3, AXL, and MERTK). Our previous study has shown that AXL expression was markedly upregulated in liver transplantation patients. However, the underlying mechanism of AXL in hepatic I/R injury remains unclear.
Targeted Restoration of GPX3 Attenuates Renal Ischemia/Reperfusion Injury by Balancing Selenoprotein Expression and Inhibiting ROS-mediated Mitochondrial Apoptosis
Renal ischemia/reperfusion (IR) injury is the leading cause of acute kidney injury in both autologous and transplanted kidneys. Low-level glutathione peroxidase 3 (GPX3) is associated with renal IR injury. The exact mechanism of targeted GPX3 restoration in renal IR injury has yet to be determined.
National Trends in Utilization of Normothermic Machine Perfusion in DCD Liver Transplantation
In liver transplantation, advances in ex situ normothermic machine perfusion (NMP) have improved outcomes compared with traditional static cold storage (SCS) in donation after circulatory death (DCD) organs. We aimed to characterize trends in the utilization of NMP versus SCS in DCD liver transplantation in the United States.
Reanimating Pancreatic Grafts Subjected to Prolonged Cold Ischemic Injury Using Normothermic Ex Vivo Perfusion
Pancreas transplant volumes are limited because of poor utilization of “extended criteria grafts.” Prolonged cold ischemia is a risk factor associated with poor allograft survival. We aimed to establish the feasibility of transplantation using grafts subjected to prolonged cold ischemia and determine whether these grafts could be optimized using normothermic ex vivo perfusion (NEVP) in a porcine model.
TID has launched a survey to develop quality indicators for managing infections in transplantation, aiming to improve patient outcomes. They seek input from centers worldwide to understand their data and mechanisms for handling post-transplant infections. This will enable collaboration with international organizations to create robust indicators. Only one representative per center is needed, preferably with an administrator. Your participation is crucial for advancing the field of Transplant Infectious Disease. Thank you for your contribution!